126 related articles for article (PubMed ID: 37963566)
1. The Antipsychotic Drug Penfluridol Inhibits N-Linked Glycoprotein Processing and Enhances T-cell-Mediated Tumor Immunity.
Xu W; Wang Y; Zhang N; Lin X; Zhu D; Shen C; Wang X; Li H; Xue J; Yu Q; Lu X; Zhou L; He Q; Tang Z; He S; Fan J; Pan J; Tang J; Jiang W; Ye M; Lu F; Li Z; Dang Y
Mol Cancer Ther; 2024 May; 23(5):648-661. PubMed ID: 37963566
[TBL] [Abstract][Full Text] [Related]
2. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
3. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response.
Hung WY; Chang JH; Cheng Y; Cheng GZ; Huang HC; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Death Dis; 2019 Jul; 10(8):538. PubMed ID: 31308361
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.
Verdura S; Cuyàs E; Cortada E; Brunet J; Lopez-Bonet E; Martin-Castillo B; Bosch-Barrera J; Encinar JA; Menendez JA
Aging (Albany NY); 2020 Jan; 12(1):8-34. PubMed ID: 31901900
[TBL] [Abstract][Full Text] [Related]
5. Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis.
Xue Q; Liu Z; Feng Z; Xu Y; Zuo W; Wang Q; Gao T; Zeng J; Hu X; Jia F; Zhu Y; Xia Y; Yu L
Biomed Pharmacother; 2020 Jan; 121():109598. PubMed ID: 31733572
[TBL] [Abstract][Full Text] [Related]
6. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis.
Tung MC; Lin YW; Lee WJ; Wen YC; Liu YC; Chen JQ; Hsiao M; Yang YC; Chien MH
Cell Death Dis; 2022 Apr; 13(4):400. PubMed ID: 35461314
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis.
Wu L; Liu YY; Li ZX; Zhao Q; Wang X; Yu Y; Wang YY; Wang YQ; Luo F
Asian Pac J Cancer Prev; 2014; 15(1):489-94. PubMed ID: 24528079
[TBL] [Abstract][Full Text] [Related]
8. Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.
Ashraf-Uz-Zaman M; Sajib MS; Cucullo L; Mikelis CM; German NA
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3652-3657. PubMed ID: 30389290
[TBL] [Abstract][Full Text] [Related]
9. Penfluridol triggers mitochondrial-mediated apoptosis and suppresses glycolysis in colorectal cancer cells through down-regulating hexokinase-2.
Wang NN; Zhang PZ; Zhang J; Wang HN; Li L; Ren F; Dai PF; Li H; Lv XF
Anat Rec (Hoboken); 2021 Mar; 304(3):520-530. PubMed ID: 32470200
[TBL] [Abstract][Full Text] [Related]
10. Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis.
Srivastava S; Zahra FT; Gupta N; Tullar PE; Srivastava SK; Mikelis CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979394
[No Abstract] [Full Text] [Related]
11. Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth.
Ranjan A; Wright S; Srivastava SK
Oncotarget; 2017 Jul; 8(29):47632-47641. PubMed ID: 28512255
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human Tumors.
Shi S; Gu S; Han T; Zhang W; Huang L; Li Z; Pan D; Fu J; Ge J; Brown M; Zhang P; Jiang P; Wucherpfennig KW; Liu XS
Clin Cancer Res; 2020 Nov; 26(22):5990-6002. PubMed ID: 32723834
[TBL] [Abstract][Full Text] [Related]
13. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.
Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH
J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW; Lim SO; Xia W; Lee HH; Chan LC; Kuo CW; Khoo KH; Chang SS; Cha JH; Kim T; Hsu JL; Wu Y; Hsu JM; Yamaguchi H; Ding Q; Wang Y; Yao J; Lee CC; Wu HJ; Sahin AA; Allison JP; Yu D; Hortobagyi GN; Hung MC
Nat Commun; 2016 Aug; 7():12632. PubMed ID: 27572267
[TBL] [Abstract][Full Text] [Related]
15. Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.
Ranjan A; Srivastava SK
Oncotarget; 2017 May; 8(20):32960-32976. PubMed ID: 28380428
[TBL] [Abstract][Full Text] [Related]
16. Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.
Ranjan A; Gupta P; Srivastava SK
Cancer Res; 2016 Feb; 76(4):877-90. PubMed ID: 26627008
[TBL] [Abstract][Full Text] [Related]
17. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
[TBL] [Abstract][Full Text] [Related]
18. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer.
Zhang YF; Zhang ZH; Li MY; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Zuo HX; Jin HL; Ma J; Jin X
Phytomedicine; 2021 Jan; 81():153425. PubMed ID: 33310309
[TBL] [Abstract][Full Text] [Related]
19. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent.
Tuan NM; Lee CH
Molecules; 2019 Oct; 24(20):. PubMed ID: 31614431
[TBL] [Abstract][Full Text] [Related]
20. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
Front Immunol; 2021; 12():654463. PubMed ID: 34054817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
